TICKERNOMICS Sign up
Last Update: 2024-12-27 15:24:29
BIOLIFE SOLUTIONS INC ( BLFS ) https://www.biolifesolutions.com
27.03USD
Sector:
Healthcare
Industry:
Medical Instruments & Supplies
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
27.80%
BLFS
61.66%
SPY
32.66%
-32.19%
BLFS
SPY
108.59%
BLFS
65.52%
SPY
302.52%
BLFS
1490.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
1248.12
1240.21
0.13
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-27.12
10.12
3.83
0.51
0.00
-161.46
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
-5.10
71.33
-6.34
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
11.5696
-8.20
-4.13
1.97
Other Earnings and Cash Flow Stats:
BIOLIFE SOLUTIONS INC ( BLFS ) Net Income TTM ($MM) is -46.03
BIOLIFE SOLUTIONS INC ( BLFS ) Operating Income TTM ($MM) is -28.05
BIOLIFE SOLUTIONS INC ( BLFS ) Owners' Earnings Annual ($MM) is 0.00
BIOLIFE SOLUTIONS INC ( BLFS ) Current Price to Owners' Earnings ratio is 0.00
BIOLIFE SOLUTIONS INC ( BLFS ) EBITDA TTM ($MM) is -19.63
BIOLIFE SOLUTIONS INC ( BLFS ) EBITDA Margin is -6.34%
Capital Allocation:
BIOLIFE SOLUTIONS INC ( BLFS ) has paid 0.00 dividends per share and bought back -2.604907 million shares in the past 12 months
BIOLIFE SOLUTIONS INC ( BLFS ) has reduced its debt by 21.23 million USD in the last 12 months
Capital Structure:
BIOLIFE SOLUTIONS INC ( BLFS ) Interest-bearing Debt ($MM) as of last quarter is 26
BIOLIFE SOLUTIONS INC ( BLFS ) Annual Working Capital Investments ($MM) are 2
BIOLIFE SOLUTIONS INC ( BLFS ) Book Value ($MM) as of last quarter is 325
BIOLIFE SOLUTIONS INC ( BLFS ) Debt/Capital as of last quarter is 8%
Other Balance Sheet Stats:
BIOLIFE SOLUTIONS INC ( BLFS ) has 23 million in cash on hand as of last quarter
BIOLIFE SOLUTIONS INC ( BLFS ) has 32 million of liabilities due within 12 months, and long term debt 20 as of last quarter
BIOLIFE SOLUTIONS INC ( BLFS ) has 46 common shares outstanding as of last quarter
BIOLIFE SOLUTIONS INC ( BLFS ) has 0 million USD of preferred stock value
Academic Scores:
BIOLIFE SOLUTIONS INC ( BLFS ) Altman Z-Score is 12.41 as of last quarter
BIOLIFE SOLUTIONS INC ( BLFS ) Piotroski Score is 6.00 as of last quarter
Corporate Governance:
BIOLIFE SOLUTIONS INC ( BLFS ) largest shareholder is owning shares at 0.00 ($MM) value
Mathew Aby J.(an insider) Sold 13196 shares of BIOLIFE SOLUTIONS INC ( BLFS ) for the amount of $358403.36 on 2024-12-17
2.01% of BIOLIFE SOLUTIONS INC ( BLFS ) is held by insiders, and 100.10% is held by institutions
BIOLIFE SOLUTIONS INC ( BLFS ) went public on 1989-11-22
Other BIOLIFE SOLUTIONS INC ( BLFS ) financial metrics:
FCF:5.65
Unlevered Free Cash Flow:0.00
EPS:-0.15
Operating Margin:-5.10
Gross Profit Margin:71.33
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:-2.09
Beta:1.97
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About BIOLIFE SOLUTIONS INC ( BLFS ) :
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; ultra-low temperature mechanical freezers; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage services. It markets and sells its products directly, as well as through third party distributors. BioLife Solutions, Inc. was incorporated in 1987 and is headquartered in Bothell, Washington.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.